These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20069756)

  • 1. Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent.
    Fagète S; Ravn U; Gueneau F; Magistrelli G; Kosco-Vilbois MH; Fischer N
    MAbs; 2009; 1(3):288-96. PubMed ID: 20069756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.
    Fagète S; Rousseau F; Magistrelli G; Gueneau F; Ravn U; Kosco-Vilbois MH; Fischer N
    J Biol Chem; 2012 Jan; 287(2):1458-67. PubMed ID: 22041899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
    Lamdan H; Gavilondo JV; Muñoz Y; Pupo A; Huerta V; Musacchio A; Pérez L; Ayala M; Rojas G; Balint RF; Larrick JW
    Mol Biosyst; 2013 Aug; 9(8):2097-106. PubMed ID: 23702826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
    Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
    Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.
    Groves MA; Amanuel L; Campbell JI; Rees DG; Sridharan S; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2014; 6(1):236-45. PubMed ID: 24256948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.
    Eteshola E
    J Immunol Methods; 2010 Jun; 358(1-2):104-10. PubMed ID: 20382151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and evaluation of an antibody phage display library targeting heparan sulfate.
    Damen LAA; van de Westerlo EMA; Versteeg EMM; van Wessel T; Daamen WF; van Kuppevelt TH
    Glycoconj J; 2020 Aug; 37(4):445-455. PubMed ID: 32468289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
    Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
    Kato M; Hanyu Y
    J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).
    Tu C; Terraube V; Tam AS; Stochaj W; Fennell BJ; Lin L; Stahl M; LaVallie ER; Somers W; Finlay WJ; Mosyak L; Bard J; Cunningham O
    J Biol Chem; 2016 Jan; 291(3):1267-76. PubMed ID: 26515064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
    Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
    MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of scFv peptide-binding specificity for crystal chaperone development.
    Pai JC; Culver JA; Drury JE; Motani RS; Lieberman RL; Maynard JA
    Protein Eng Des Sel; 2011 May; 24(5):419-28. PubMed ID: 21217145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
    J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].
    Zhao Y; Wang QM; Fu XQ; Chen JZ; Fan GC; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):667-72. PubMed ID: 15973987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.
    Fennell BJ; McDonnell B; Tam AS; Chang L; Steven J; Broadbent ID; Gao H; Kieras E; Alley J; Luxenberg D; Edmonds J; Fitz LJ; Miao W; Whitters MJ; Medley QG; Guo YJ; Darmanin-Sheehan A; Autin B; Shúilleabháin DN; Cummins E; King A; Krebs MR; Grace C; Hickling TP; Boisvert A; Zhong X; McKenna M; Francis C; Olland S; Bloom L; Paulsen J; Somers W; Jensen A; Lin L; Finlay WJ; Cunningham O
    MAbs; 2013; 5(6):882-95. PubMed ID: 23995618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.